TFFP - Kapitalisasi marang volume dodolan TFF Pharmaceuticals Inc.
The normalized P/S of TFF Pharmaceuticals (TFFP) on the GURU.Markets time-series chart, where the value 22.30 corresponds to the current metric, is based on the potential for licensing royalties from pharma behemoths. The business relies on innovations in the creation of dry powders for inhalation, establishing a technological barrier. However, geopolitical conflicts and sanctions restrict access to components and narrow global sales markets.
Rincian metrik lan analitis perusahaan TFF Pharma (TFFP)
- rega saham lan konsensus proyeksi valuasi:
- statistik kapitalisasi pasar:
- informasi kapitalisasi buku:
- statistik kawajiban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi TFF Pharmaceuticals|TFFP - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas TFF Pharmaceuticals, Inc|TFFP - Gunggung utang perusahaan|Rasio utang marang aset resik TFF Pharma|TFFP - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan TFF Pharmaceuticals|Rasio jangkoan perantara tffpharma.com
- indikator bathi lan kelipatan valuasi:
TFFP - Bathi resik perusahaan|Bathi mangsa ngarep TFF Pharmaceuticals|TFFP - Pangali P/E|Pangali Forward P/E TFF Pharmaceuticals Inc.|TFFP - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan TFF Pharma|TFFP - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan TFF Pharmaceuticals|TFFP - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan tffpharma.com|TFFP - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep TFF Pharmaceuticals
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:tffpharma.com, TFFP
The P/S ratio determines the market value of a business relative to its annual sales volume, measuring the premium investors are willing to pay per unit of revenue. Analyzing the P/S ratio dynamics of TFF Pharmaceuticals (TFFP) reveals how the loss of fundamental value due to asset liquidation and the cessation of operations transforms the metric into an indicator of pure speculative decay.
Perusahaan pesaing
HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Kenvue - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan VRNA (Verona Pharma PLC)|Jyong Biotech Corp - Multiplikator P/S|Rasio rega marang dodolan LGND|AMRX: Multiplikator P/S|Rasio rega marang dodolan PRGO (perrigo.com)|Kapitalisasi marang pendapatan ALVO|LQDA: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Galapagos Genomics (GLPG)|ANIP: Rasio rega marang dodolan|Multiplikator P/S MNKD (MannKind Corporation)|Rasio kapitalisasi pasar marang pendapatan AMPH|Pacira BioSciences, Inc. - Multiplikator P/S|SPRY - Multiplikator P/S|Theravance (TBPH) - Rasio rega marang pendapatan|Aquestive Corp - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan scPharmaceuticals, Inc.|Kapitalisasi marang pendapatan Tectonic (TECX)|Multiplikator P/S TNXP|Multiplikator P/S sxtchina.com (SXTC)|Multiplikator P/S EPRX (Eupraxia Pharmaceuticals Inc.)|BHST - Kapitalisasi marang pendapatan|eXoZymes Inc - Multiplikator P/S|Rega marang dodolan Oramed Pharmaceuticals|ENTX (enterabio.com) - Kapitalisasi marang pendapatan|MindWalk Holdings, Inc. (HYFT) - Multiplikator P/S|Kapitalisasi marang pendapatan ABVC|CPIX (Cumberland Corp) - Kapitalisasi marang volume dodolan|Multiplikator P/S QNTM|Koefisien rega marang pendapatan fibrogen.com|Multiplikator P/S TELO (Telomir Pharmaceuticals, Inc.)|RANI - Kapitalisasi marang pendapatan|Synergy CHC Corporation - Multiplikator P/S|RLYB - Multiplikator P/S|lexariabioscience.com (LEXX) - Rasio rega marang pendapatan|PULM (pulmatrix.com) - Rasio rega marang pendapatan|Rasio rega marang pendapatan Pheton Holdings Limited|Aptorum (APM) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan LYRA (Lyra Therapeutics, Inc)|Kapitalisasi marang volume dodolan IBO|Multiplikator P/S TNFA (TNF Pharmaceuticals, Inc.)|YCBD (cbdMD Inc.) - Rasio rega marang dodolan|PainReform - Multiplikator P/S|Rasio rega marang dodolan CYTO|Lipella (LIPO) - Rasio rega marang pendapatan|Rasio rega marang dodolan OPTN (OptiNose Corp)|Rasio rega marang pendapatan Pieris Pharmaceuticals|procapsgroup.com - Rasio rega marang dodolan|Multiplikator P/S PTPI|QLI (Qilian International Holding Group) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S SLRN (ACELYRIN, Inc.)
